Unichem Laboratories Limited (BOM:506690)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals		21.11B	17.85B	13.43B	12.70B	12.35B
Pharmaceuticals Growth		18.25%	32.92%	5.76%	2.81%	11.91%
Total		21.11B	17.85B	13.43B	12.70B	12.35B
Total Growth		18.25%	32.92%	5.76%	2.81%	11.91%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India		407.40M	409.80M	322.11M	412.52M	370.66M
India Growth		-0.59%	27.22%	-21.92%	11.29%	26.90%
USA		13.25B	10.86B	7.86B	7.34B	7.08B
USA Growth		22.06%	38.23%	6.98%	3.77%	10.97%
Others		6.98B	6.11B	4.85B	4.72B	4.45B
Others Growth		14.34%	26.02%	2.58%	6.11%	16.34%
Total		20.64B	17.38B	13.02B	12.48B	11.90B
Total Growth		18.81%	33.42%	4.36%	4.88%	13.37%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error